Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
MLO Med Lab Obs ; 37(3): 20-7, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15828363
3.
Psychiatry Res ; 131(1): 11-21, 2004 May 30.
Article in English | MEDLINE | ID: mdl-15246451

ABSTRACT

The effects of auditory statements describing a personal worry on brain activation as measured by functional magnetic resonance imaging were examined in patients with generalized anxiety disorder (GAD) before and after anxiety reduction with citalopram. Six patients were imaged while listening to verbal descriptions of a personal worry or a neutral statement before treatment with citalopram and after 7 weeks of treatment. Pre-post drug analyses showed treatment with citalopram reduced self-reported anxiety and reduced BOLD responses to a pathology-specific worry and a neutral stimulus. After treatment, worry sentences, compared to neutral statements, elicit reduced BOLD responses in prefrontal regions, the striatum, insula and paralimbic regions. In addition, contrasts before and after treatment revealed reductions in the differential response that existed between worry and neutral statements. Overall reduction of BOLD response was most prominent during neutral statements, particularly in the left hemisphere. These findings support the clinical impression that GAD patients overreact to both pathology-specific and non-specific cues and that the reduction of anxiety attenuates the response to both types of cues.


Subject(s)
Anti-Anxiety Agents/therapeutic use , Anxiety Disorders/drug therapy , Arousal/drug effects , Brain/drug effects , Citalopram/therapeutic use , Image Enhancement , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Selective Serotonin Reuptake Inhibitors/therapeutic use , Adult , Anti-Anxiety Agents/adverse effects , Anxiety Disorders/physiopathology , Anxiety Disorders/psychology , Brain/physiopathology , Brain Mapping , Citalopram/adverse effects , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Humans , Limbic System/drug effects , Limbic System/physiopathology , Male , Prefrontal Cortex/drug effects , Prefrontal Cortex/physiopathology , Selective Serotonin Reuptake Inhibitors/adverse effects , Speech Perception/drug effects , Speech Perception/physiology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...